| Dr Ioannis Papadopoulos, MD | |
|
1112 6th Ave Ste 200, Tacoma, WA 98405-4048 | |
| (253) 272-8664 | |
| (253) 627-7880 |
| Full Name | Dr Ioannis Papadopoulos |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 23 Years |
| Location | 1112 6th Ave Ste 200, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215015383 | NPI | - | NPPES |
| 2175414 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 60309971 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Medical Center | Tacoma, WA | Hospital |
| St Elizabeth Hospital | Enumclaw, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of the People's Republic of China (PRC) has issued a Notification of Granting Patent Rights for PRC 200480018784 which includes the use of nucleic acids, e.g., an siRNA, for the treatment of cancer. The patent describes modulation of claudins, which are proteins implicated in tumor progression and metastasis.
Buying more time for budget talks, the House Appropriations Committee unveiled a three-week stop-gap bill Friday that will carry the government through April 8 while Republicans and the White House try to hammer out a spending plan for the second half of this fiscal year.
With many American children overweight and obese, Smart for Life's new THIN ADVENTURE(TM) Children's Weight Loss Program introduces an affordable 30-day weight-loss program designed for children between the ages of 6 and 14. It will be available at http://www.smartforlife.com and other affiliated retailers in January 2010.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
› Verified 9 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of the People's Republic of China (PRC) has issued a Notification of Granting Patent Rights for PRC 200480018784 which includes the use of nucleic acids, e.g., an siRNA, for the treatment of cancer. The patent describes modulation of claudins, which are proteins implicated in tumor progression and metastasis.
Buying more time for budget talks, the House Appropriations Committee unveiled a three-week stop-gap bill Friday that will carry the government through April 8 while Republicans and the White House try to hammer out a spending plan for the second half of this fiscal year.
With many American children overweight and obese, Smart for Life's new THIN ADVENTURE(TM) Children's Weight Loss Program introduces an affordable 30-day weight-loss program designed for children between the ages of 6 and 14. It will be available at http://www.smartforlife.com and other affiliated retailers in January 2010.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ioannis Papadopoulos, MD 1112 6th Ave Ste 200, Tacoma, WA 98405-4048 Ph: (253) 272-8664 | Dr Ioannis Papadopoulos, MD 1112 6th Ave Ste 200, Tacoma, WA 98405-4048 Ph: (253) 272-8664 |
News Archive
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of the People's Republic of China (PRC) has issued a Notification of Granting Patent Rights for PRC 200480018784 which includes the use of nucleic acids, e.g., an siRNA, for the treatment of cancer. The patent describes modulation of claudins, which are proteins implicated in tumor progression and metastasis.
Buying more time for budget talks, the House Appropriations Committee unveiled a three-week stop-gap bill Friday that will carry the government through April 8 while Republicans and the White House try to hammer out a spending plan for the second half of this fiscal year.
With many American children overweight and obese, Smart for Life's new THIN ADVENTURE(TM) Children's Weight Loss Program introduces an affordable 30-day weight-loss program designed for children between the ages of 6 and 14. It will be available at http://www.smartforlife.com and other affiliated retailers in January 2010.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
› Verified 9 days ago
Dr. Christoffer Aaron Spoja, D.O. Gastroenterology Medicare: Medicare Enrolled Practice Location: Madigan Army Medical Ctr, Tacoma, WA 98431 Phone: 253-968-0208 | |
Christen E Eidal, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1291 | |
Ms. Jessica Wai-ying Tam, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1717 S J St, Tacoma, WA 98405 Phone: 253-426-6341 Fax: 253-426-6344 | |
Bryan Wilson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 612-916-8558 | |
Dr. Richard Lyle Urbon Jr., M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9040a Jackson Ave, Tacoma, WA 98431 Phone: 253-968-0166 | |
Roger Jay Stegman, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 9040 Reid St, Attn Mchj Qcr Madigan Army Medical Center, Tacoma, WA 98431 Phone: 253-968-2252 Fax: 253-968-3278 | |
Mohammad Qasim Baig, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1291 |